AMICUS THERAPEUTICS INC. - COMMON STOCK
7.5200
26-八月-25 13:45:00
15 分钟延时
股票
+0.0400
+0.53%
今日范围
7.4000 - 7.5600
ISIN
N/A
来源
NASDAQ
-
Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates
09 11月 2021 04:00:04 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Third Quarter 2021 Financial Results on November 9, 2021
03 11月 2021 04:00:01 条件 Nasdaq GlobeNewswire
-
29 9月 2021 03:30:00 条件 Nasdaq GlobeNewswire
-
U.S. FDA Accepts Filings for Amicus’ AT-GAA for the Treatment of Pompe Disease
29 9月 2021 03:30:00 条件 Nasdaq GlobeNewswire
-
20 9月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021
03 9月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
02 8月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
27 7月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors
14 6月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
28 5月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
21 5月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates
10 5月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021
07 5月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
06 5月 2021 04:00:02 条件 Nasdaq GlobeNewswire
-
05 5月 2021 04:00:01 条件 Nasdaq GlobeNewswire
-
03 5月 2021 04:00:01 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics Recognized as a Great Place to Work® in Europe
28 4月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce First Quarter 2021 Financial Results on May 10, 2021
26 4月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
15 3月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2020 Financial Results and Corporate Updates
01 3月 2021 04:00:02 条件 Nasdaq GlobeNewswire